Specifications include, but are not limited to: Both rapid antigen test kits (authorized for use by the U.S. Food and Drug Administration (FDA)), and laboratory-based Polymerase Chain Reaction (PCR) tests; both of which are critical tools to mitigate community transmission of COVID-19. 1) Designated as Point of Care Testing Kits o Possesses a valid Emergency Use Authorization from the FDA for the detection of SARS-CoV-2 o Able to be performed on persons of all ages o Anterior nasal collection specifications (preferred) o Able to be analyzed without the assistance of additional instrumentation (preferred) 2) Designated as At-Home Testing Kits o Possesses a valid Emergency Use Authorization from the FDA for the detection of SARS-CoV-2 o Able to be performed on all persons with a minimum age of two (2) years o Anterior nasal collection only
